These investments are another important step in the company’s aggressive, four-phase initiative to reorganize, restructure, divest non-core assets, and invest for accelerated growth, which was announced in August of 2020.
The company has acquired Allevi, Inc. to expand regenerative medicine initiative by accelerating growth in medical and pharmaceutical research laboratories.
3D Systems has also acquired German software firm, Additive Works GmbH to expand simulation capabilities for rapid optimisation of industrial-scale 3D printing processes - see video.
3D Systems’ president and CEO, Dr. Jeffrey Graves, said: “We continue to deliver on our four-phase plan with an increasing focus on investing for accelerated growth and profitability. I’m excited by the expertise, capabilities and technologies we are adding to the 3D Systems portfolio with Allevi and Additive Works.
"Through these investments, we are enriching our solutions portfolio to address a much broader healthcare market, including the extremely exciting market for regenerative medicine, while accelerating the adoption rate for AM across industrial applications.
"These investments will bring added value to our customers, open new markets for our technology, and result in accelerated growth and profitability that will allow 3D Systems to thrive in the exciting years ahead.”
Read more here.
